Extensive three-dimensional intratumor proteomic heterogeneity revealed by multiregion sampling in high-grade serous ovarian tumor specimens

AL Hunt, NW Bateman, W Barakat, S Makohon-Moore… - Iscience, 2021 - cell.com
Enriched tumor epithelium, tumor-associated stroma, and whole tissue were collected by
laser microdissection from thin sections across spatially separated levels of ten high-grade …

Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling

AL Hunt, NW Bateman, W Barakat… - Clinical proteomics, 2024 - Springer
Background Although uterine serous carcinoma (USC) represents a small proportion of all
uterine cancer cases, patients with this aggressive subtype typically have high rates of …

Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma

L Geistlinger, S Oh, M Ramos, L Schiffer, RS LaRue… - Cancer research, 2020 - AACR
Multiple studies have identified transcriptome subtypes of high-grade serous ovarian
carcinoma (HGSOC), but their interpretation and translation are complicated by tumor …

Spatially resolved transcriptomics of high-grade serous ovarian carcinoma

E Stur, S Corvigno, M Xu, K Chen, Y Tan, S Lee, J Liu… - Iscience, 2022 - cell.com
Bulk and single-cell RNA sequencing do not provide full characterization of tissue spatial
diversity in cancer samples, and currently available in situ techniques (multiplex …

Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes

TT Gong, S Guo, FH Liu, YL Huo, M Zhang… - Nature …, 2023 - nature.com
Clear cell carcinoma (CCC), endometrioid carcinoma (EC), and serous carcinoma (SC) are
the major histological subtypes of epithelial ovarian cancer (EOC), whose differences in …

Sio: A spatioimageomics pipeline to identify prognostic biomarkers associated with the ovarian tumor microenvironment

Y Zhu, S Ferri-Borgogno, J Sheng, TL Yeung, JK Burks… - Cancers, 2021 - mdpi.com
Simple Summary High-grade serous ovarian cancer (HGSC) caused more than 13,000
deaths annually in the United States. A critically important component that influences the …

Multisite tumor sampling reveals extensive heterogeneity of tumor and host immune response in ovarian cancer

S Lakis, V Kotoula, GA Koliou, I Efstratiou… - Cancer Genomics & …, 2020 - cgp.iiarjournals.org
Background/Aim: Ovarian cancer (OVCA) is characterized by genomic/molecular intra-
patient heterogeneity (IPH). Tissue histology and morphological features are surrogates of …

Differential protein mapping of ovarian serous adenocarcinomas: identification of potential markers for distinct tumor stage

Y Wang, R Wu, KR Cho, DG Thomas… - Journal of proteome …, 2009 - ACS Publications
Ovarian serous carcinomas (OSCs) comprise over half of all ovarian carcinomas and
account for the majority of ovarian cancer-related deaths. We used a 2-dimensional liquid …

Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors

W Wegdam, CA Argmann, G Kramer, JP Vissers… - PLoS …, 2014 - journals.plos.org
Purpose To identify proteins and (molecular/biological) pathways associated with
differences between benign and malignant epithelial ovarian tumors. Experimental …

Comparative proteomic analysis of low stage and high stage endometrioid ovarian adenocarcinomas

H Kim, R Wu, KR Cho, DG Thomas… - PROTEOMICS …, 2008 - Wiley Online Library
Ovarian cancer, the second most common gynecological malignancy, accounts for 3% of all
cancers among women in the United States, and has a high mortality rate, largely because …